Ángel Chamorro
Head of the Cerebral Vascular Pathology UnitResearch group
- Cerebrovascular diseases Group leader (R4)
About me
Dr. Chamorro is a vascular neurologist, Professor of Neurology at the University of Barcelona, and Adjunct Professor at the University of Iowa. He has served as Vice President of the European Stroke Organization (ESO). He founded and directs the Functional Stroke Unit at the Hospital Clínic of Barcelona. He has led key clinical trials that have been incorporated into the International Therapeutic Guidelines for Stroke. He is the founder of FreeOx Biotech, a spin off of the Hospital Clínic dedicated to the development of redox based therapies for stroke. He has been a pioneer in identifying the importance of enhancing cerebral microcirculatory perfusion to improve the net clinical benefits of mechanical thrombectomy.
Featured publications
-
Uric Acid Stroke Cerebroprotection Transcended Sex, Age, and Comorbidities in a Multicenter Preclinical Trial
Authors:Reference: STROKE 2025. -
Effects of Achieving Rapid, Intensive, and Sustained Blood Pressure Reduction in Intracerebral Hemorrhage Expansion and Functional Outcome
Authors:Reference: NEUROLOGY 2024. -
Intravenous Thrombolysis before Complete Angiographic Reperfusion: Beyond Angiographic Assessment to Target Microvascular Obstruction?
Authors:Reference: ANNALS OF NEUROLOGY 2024. -
Uric Acid: A Translational Journey in Cerebroprotection That Spanned Preclinical and Human Data
Authors:Reference: NEUROLOGY 2023. -
Cerebrovascular Events in Older Patients With Patent Foramen Ovale: Current Status and Future Perspectives
Authors:Reference: Journal of Stroke 2023. -
A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke
Authors:Reference: Science Translational Medicine 2023. -
Poststroke Lung Infection by Opportunistic Commensal Bacteria Is Not Mediated by Their Expansion in the Gut Microbiota
Authors:Reference: STROKE 2023. -
Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial
Authors:Reference: STROKE 2022. -
Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial
Authors:Reference: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2022.
Featured Projects
-
Inhibición del complemento para optimizar la recuperación funcional en el ictus isquémico
Principal investigator: Xabier Urra Nuin, Ángel Chamorro SanchezFunder: Instituto de Salud Carlos IIICode: PI24/00446Duration: 01/01/2025 - 31/12/2027 -
Redes de Investigación Cooperativa Orientada a Resultados en Salud 2024 (RICORS24): Enfermedades vasculares cerebrales RICORS-ICTUS
Funder: Instituto de Salud Carlos IIICode: RD24/0009/0002Duration: 01/01/2025 - 31/12/2027 -
Optimización química de la embolectomía cerebral en pacientes con accidente cerebrovascular agudo tratados con trombectomía mecánica (ENSAYO CHOICE-2)
Principal investigator: Ángel Chamorro SanchezFunder: Instituto de Salud Carlos IIIDuration: 01/01/2023 -
Estudio multimodal de los determinantes del destino tisular y la recuperación funcional en el infarto cerebral maligno
Principal investigator: Xabier Urra Nuin, Ángel Chamorro SanchezFunder: Instituto de Salud Carlos IIICode: PI21/00966Duration: 01/01/2022 - 31/12/2024 -
Anti-inflammatory miRNA nanoshuttles as therapeutic strategy for stroke (NANO4STROKE)
Principal investigator: Anna Planas ObradorsFunder: European Commission - Instituto de Salud Carlos IIICode: AC20/00052Duration: 01/01/2021 - 31/12/2023
